Quarterly Result6 Aug 2026, 01:54 pm
Krebs Biochemicals Q1 FY27 Net Loss ₹248.48 Lakhs
AI Summary
Krebs Biochemicals & Industries Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported a net loss of ₹248.48 lakhs for the quarter. Revenue from operations stood at ₹1,038.80 lakhs. The company's board also approved the amalgamation of Krebs Biochemicals with Ipca Laboratories Limited, with an appointed date of April 1, 2026. The Vizag manufacturing unit remains closed due to a Pollution Control Board order.
Key Highlights
- Q1 FY27 net loss reported at ₹248.48 lakhs.
- Revenue from operations for Q1 FY27 was ₹1,038.80 lakhs.
- Board approved amalgamation with Ipca Laboratories Limited.
- Vizag manufacturing unit continues to be closed.
- Auditors issued an unmodified report on the financial results.
Price Impact
More from KREBSBIO